182 related articles for article (PubMed ID: 29720863)
21. Hepatitis B virus coinfection in patients treated for chronic hepatitis C: clinical characteristics, risk of reactivation with long-term follow-up, and effectiveness of antiviral therapy.
Zarębska-Michaluk D; Brzdęk M; Rzymski P; Dobrowolska K; Flisiak R
Pol Arch Intern Med; 2024 Jan; 134(1):. PubMed ID: 38164525
[TBL] [Abstract][Full Text] [Related]
22. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
23. Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment.
Liu CJ; Sheen IS; Chen CY; Chuang WL; Wang HY; Tseng KC; Chang TT; Yang J; Massetto B; Suri V; Camus G; Jiang D; Zhang F; Gaggar A; Hu TH; Hsu YC; Lo GH; Chu CJ; Chen JJ; Peng CY; Chien RN; Chen PJ
Clin Infect Dis; 2022 Aug; 75(3):453-459. PubMed ID: 34864948
[TBL] [Abstract][Full Text] [Related]
24. Risk of hepatitis B virus reactivation with direct-acting antivirals against hepatitis C virus: A cohort study from Egypt and meta-analysis of published data.
El Kassas M; Shimakawa Y; Ali-Eldin Z; Funk AL; Wifi MN; Zaky S; El-Raey F; Esmat G; Fontanet A
Liver Int; 2018 Dec; 38(12):2159-2169. PubMed ID: 29738637
[TBL] [Abstract][Full Text] [Related]
25. A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort.
Yen YH; Kee KM; Kuo FY; Chang KC; Hu TH; Lu SN; Wang JH; Hung CH; Chen CH
Medicine (Baltimore); 2018 Dec; 97(50):e13383. PubMed ID: 30557991
[TBL] [Abstract][Full Text] [Related]
26. Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection.
Coppola N; Marrone A; Pisaturo M; Starace M; Signoriello G; Gentile I; Adinolfi LE; Sagnelli E; Zampino R
Eur J Clin Microbiol Infect Dis; 2014 Apr; 33(4):559-67. PubMed ID: 24081499
[TBL] [Abstract][Full Text] [Related]
27. HBV reactivation during direct-acting antiviral therapy in hepatitis B and C coinfected patients undergoing haemodialysis.
Wang J; Hu C; Chen Y; Liu Z; Yu Q; Yang S; Dong J; Yang Y; Wu Y; Ren D; Yao N; Guo D; Tian Z; Zhao Y; Chen T; He Y; Liu J
Antivir Ther; 2019; 24(2):77-84. PubMed ID: 30833515
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C.
Toka B; Köksal AŞ; Dertli R; Şirin G; Fidan S; Ülger Y; Harmandar F; Yıldırım AE; Eminler AT; Asil M; Kayar Y; Bıyık M; Kuran S; Uslan MI; Hülagü S
Dig Dis; 2022; 40(5):635-643. PubMed ID: 35108715
[TBL] [Abstract][Full Text] [Related]
29. Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA.
Jaroszewicz J; Pawłowska M; Simon K; Zarębska-Michaluk D; Lorenc B; Klapaczyński J; Tudrujek-Zdunek M; Sitko M; Mazur W; Janczewska E; Paluch K; Dybowska D; Buczyńska I; Czauż-Andrzejuk A; Berak H; Krygier R; Piasecki M; Dobracka B; Citko J; Piekarska A; Socha Ł; Deroń Z; Tronina O; Laurans Ł; Białkowska J; Tomasiewicz K; Halota W; Flisiak R
Expert Rev Anti Infect Ther; 2020 Oct; 18(10):1045-1054. PubMed ID: 32538232
[TBL] [Abstract][Full Text] [Related]
30. Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients.
Pol S; Marion O; Vallet-Pichard A; Meritet JF; Sauné K; Alric L; Kamar N
Transpl Infect Dis; 2018 Jun; 20(3):e12864. PubMed ID: 29512231
[TBL] [Abstract][Full Text] [Related]
31. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
Yu ML; Lee CM; Chen CL; Chuang WL; Lu SN; Liu CH; Wu SS; Liao LY; Kuo HT; Chao YC; Tung SY; Yang SS; Kao JH; Su WW; Lin CL; Yang HC; Chen PJ; Chen DS; Liu CJ;
Hepatology; 2013 Jun; 57(6):2135-42. PubMed ID: 23322699
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.
Mücke MM; Backus LI; Mücke VT; Coppola N; Preda CM; Yeh ML; Tang LSY; Belperio PS; Wilson EM; Yu ML; Zeuzem S; Herrmann E; Vermehren J
Lancet Gastroenterol Hepatol; 2018 Mar; 3(3):172-180. PubMed ID: 29371017
[TBL] [Abstract][Full Text] [Related]
33. Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection.
Liu CJ; Chen PJ
World J Gastroenterol; 2014 Mar; 20(11):2955-61. PubMed ID: 24659886
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV).
Blackard JT; Sherman KE
Rev Med Virol; 2018 Jul; 28(4):e1984. PubMed ID: 29761585
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection.
Liu CH; Liu CJ; Su TH; Fang YJ; Yang HC; Chen PJ; Chen DS; Kao JH
Open Forum Infect Dis; 2017; 4(1):ofx028. PubMed ID: 28480296
[TBL] [Abstract][Full Text] [Related]
36. [Clinical and virological course of dual infection by hepatitis B and C viruses in China].
Fan CL; Wei L; Jiang D; Chen HS; Gao Y; Li RB; Fei R; Ji Y; Zhu L; Wang Y
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1214-8. PubMed ID: 12930633
[TBL] [Abstract][Full Text] [Related]
37. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.
Hung CH; Lu SN; Wang JH; Hu TH; Chen CH; Huang CM; Lee CM
Antivir Ther; 2011; 16(7):959-68. PubMed ID: 22024511
[TBL] [Abstract][Full Text] [Related]
38. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.
Fabbri G; Mastrorosa I; Vergori A; Mazzotta V; Pinnetti C; Grisetti S; Zaccarelli M; Ammassari A; Antinori A
BMC Infect Dis; 2017 Mar; 17(1):182. PubMed ID: 28249574
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C Virus and Hepatitis B Virus Co-Infection.
Shih YF; Liu CJ
Viruses; 2020 Jul; 12(7):. PubMed ID: 32664198
[TBL] [Abstract][Full Text] [Related]
40. Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients.
Wiegand SB; Jaroszewicz J; Potthoff A; Höner Zu Siederdissen C; Maasoumy B; Deterding K; Manns MP; Wedemeyer H; Cornberg M
Clin Microbiol Infect; 2015 Jul; 21(7):710.e1-9. PubMed ID: 25882360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
